| Diana Divra, RN | |
|
1601 Brenner Ave, Salisbury, NC 28144-2515 | |
| (800) 706-9126 | |
| Not Available |
| Full Name | Diana Divra |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 1601 Brenner Ave, Salisbury, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184359978 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 271312 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Diana Divra, RN 7460 Apple Creek Dr, Mint Hill, NC 28227-5239 Ph: (413) 275-4071 | Diana Divra, RN 1601 Brenner Ave, Salisbury, NC 28144-2515 Ph: (800) 706-9126 |
News Archive
Patients who arrive at the emergency department with low-risk chest pain and talk through treatment options with a physician show improved knowledge of their health status and follow-up options, compared with patients who received standard counseling from a physician, according to Mayo Clinic research presented at the American College of Cardiology's 65th Annual Scientific Session.
Only around a fifth of women at higher risk of developing breast cancer think they need to take a drug proven to help prevent the disease, according to new research funded by Cancer Research UK and published today (Monday) in Clinical Breast Cancer.
A BCI is an apparatus that allows an individual to control a machine or computer directly from their brain.Non-invasive means of control like electroencephalogram (EEG) readings taken through the skull are safe and convenient compared to more risky invasive methods using a brain implant, but they take longer to learn and users ultimately vary in proficiency.
The U.S. Food and Drug Administration today granted accelerated approval to Perjeta (pertuzumab) as part of a complete treatment regimen for patients with early stage breast cancer before surgery (neoadjuvant setting). Perjeta is the first FDA-approved drug for the neoadjuvant treatment of breast cancer.
In an analysis of data from a coronary care registry in Sweden, between 1996-2007 there was an increase in the prevalence of use of evidence-based invasive procedures and pharmacological therapies for treatment of a certain type of heart attack, and a decrease in the rate of death at 30 days and one year after a heart attack for these patients, according to a study in the April 27 issue of JAMA.
› Verified 9 days ago
Miss Corinne Lucinda Triplett, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1504 Jake Alexander Blvd W, Salisbury, NC 28147 Phone: 704-645-8539 | |
Barbara Elaine Morgan, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1504 Jake Alexander Blvd W, Salisbury, NC 28147 Phone: 704-645-8539 Fax: 704-645-9003 | |
Martha Puga, I.B.C.L.C. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 129 Woodson St, Salisbury, NC 28144 Phone: 704-636-5576 Fax: 704-216-2011 | |
Logan Durham, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1601 Brenner Ave, Salisbury, NC 28144 Phone: 704-638-9000 | |
Rebecca Salomon, BA, MSN, PMHNP-BC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 612 Mocksville Ave, Novant Health Psychiatric Medicine, Salisbury, NC 28144 Phone: 615-397-8039 | |
Mrs. Debra A Sheridan, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1304 Oak Grove Ln, Salisbury, NC 28146 Phone: 315-783-4530 |